Clinical Scorecard: Synergistic Use of Non-Contrast Abbreviated MRI and Alpha-Fetoprotein for Effective Hepatocellular Carcinoma Screening

At a Glance

Key Highlights

• Ultrasound (US) has limited sensitivity (47%) for early HCC detection, especially in patients with large body habitus or advanced cirrhosis.
• AFP's role in surveillance is debated but recent guidelines recommend US with or without AFP for HCC screening.
• Abbreviated MRI protocols, especially NC-AMRI and Dyn-AMRI, offer higher sensitivity and shorter acquisition times compared to complete MRI.

Guideline-Based Recommendations

Diagnosis

• Bi-annual screening with abdominal ultrasound with or without serum AFP in patients at risk for HCC.
• MRI is the reference standard for HCC diagnosis and staging but not routinely recommended for surveillance due to cost and access limitations.
• Use of abbreviated MRI protocols (NC-AMRI, Dyn-AMRI) is emerging as a promising alternative for surveillance.

Management

• Incorporate NC-AMRI combined with AFP to improve detection sensitivity for early HCC.
• Consider Dyn-AMRI for enhanced lesion characterization when available.
• Use LI-RADS 2018 criteria for lesion scoring on Dyn-AMRI and complete MRI; adapted US LI-RADS scoring for NC-AMRI.

Monitoring & Follow-up

• Perform HCC surveillance every 6 months alternating between US and MRI as per institutional practice.
• Regular follow-up in liver clinics with clinical, biological, and imaging data collection.

Risks

• Limited sensitivity of US may delay early HCC diagnosis.
• MRI surveillance limited by longer exam times, cost, and access.
• Potential for false positives or negatives depending on imaging modality and lesion size.

Patient & Prescribing Data

Adults with cirrhosis or advanced fibrosis undergoing HCC surveillance

NC-AMRI combined with AFP improves HCC detection sensitivity compared to US alone; Dyn-AMRI offers further diagnostic detail but requires contrast and longer acquisition time.

Clinical Best Practices

• Use NC-AMRI protocols including axial fat-suppressed T2-weighted imaging and diffusion-weighted imaging for efficient HCC surveillance.
• Combine imaging findings with serum AFP levels to enhance early HCC detection.
• Apply standardized lesion scoring systems (adapted US LI-RADS for NC-AMRI, LI-RADS 2018 for Dyn-AMRI and complete MRI) for consistent interpretation.
• Limit MRI surveillance to patients at high risk and consider alternating with US to balance sensitivity, cost, and accessibility.
• Ensure imaging is performed on high-field 3-T MRI systems for optimal image quality.

References

• American Association for the Study of Liver Diseases (AASLD) Guidelines
• European Association for the Study of the Liver (EASL) Clinical Practice Guidelines
• Asia-Pacific Clinical Practice Guidelines on HCC
• LI-RADS 2018 Liver Imaging Reporting and Data System